Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes Pursuant to 21 U.S.C 952; DEA Form 357, 56703 [2016-19916]
Download as PDF
Federal Register / Vol. 81, No. 162 / Monday, August 22, 2016 / Notices
56703
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
Dated: lllllllllllllllll —Minimize the burden of the collection
lllllllllllllllllllll
of information on those who are to
United States District Judge
respond, including through the use of
[FR Doc. 2016–19988 Filed 8–19–16; 8:45 am]
appropriate automated, electronic,
BILLING CODE P
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
DEPARTMENT OF JUSTICE
responses.
proposed collection: The DEA estimates
the total public burden (in hours)
associated with this collection: 333
annual burden hours.
If additional information is required
please contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Suite 3E.405B,
Washington, DC 20530.
[OMB Number 1117–0013]
Dated: August 16, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
IV.
Entry of this Final Judgment is in the
public interest.
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Application for
Permit to Import Controlled
Substances for Domestic and/or
Scientific Purposes Pursuant to 21
U.S.C 952; DEA Form 357
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
October 21, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Michael J. Lewis, Office of Diversion
Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:13 Aug 19, 2016
Jkt 238001
Overview of this information
collection:
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Permit to Import
Controlled Substances for Domestic
and/or Scientific Purposes pursuant to
21 U.S.C. 952.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form: 357. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: Section 1002 of the
Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 952) and
Title 21, Code of Federal Regulations
(21 CFR), Sections 1312.11, 1312.12 and
1312.13 requires any person who
desires to import controlled substances
listed in schedules I or II, any narcotic
substance listed in schedules III or IV,
or any non-narcotic substance in
schedule III which the Administrator
has specifically designated by regulation
in § 1312.30, or any nonnarcotic
substance in schedule IV or V which is
also listed in schedule I or II of the
Convention on Psychotropic
Substances, must have an import
permit. To obtain the permit to import
controlled substances for domestic and
or scientific purposes, an application for
the permit must be made to the DEA on
DEA Form 357.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that 151
registrants participate in this
information collection, taking an
estimated 0.25 hours per registrant
annually.
6. An estimate of the total public
burden (in hours) associated with the
PO 00000
Frm 00127
Fmt 4703
Sfmt 4703
[FR Doc. 2016–19916 Filed 8–19–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Survey of
Occupational Injuries and Illnesses
ACTION:
Notice.
The Department of Labor
(DOL) is submitting the Bureau of Labor
Statistics (BLS) sponsored information
collection request (ICR) revision titled,
‘‘Survey of Occupational Injuries and
Illnesses,’’ to the Office of Management
and Budget (OMB) for review and
approval for use in accordance with the
Paperwork Reduction Act (PRA) of 1995
(44 U.S.C. 3501 et seq.). Public
comments on the ICR are invited.
DATES: The OMB will consider all
written comments that agency receives
on or before September 21, 2016.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained free of charge from the
RegInfo.gov Web site at https://
www.reginfo.gov/public/do/
PRAViewICR?ref_nbr=201606–1220–001
(this link will only become active on the
day following publication of this notice)
or by contacting Michel Smyth by
telephone at 202–693–4129, TTY 202–
693–8064, (these are not toll-free
numbers) or sending an email to DOL_
PRA_PUBLIC@dol.gov.
Submit comments about this request
by mail or courier to the Office of
Information and Regulatory Affairs,
Attn: OMB Desk Officer for DOL–BLS,
Office of Management and Budget,
Room 10235, 725 17th Street NW.,
Washington, DC 20503; by Fax: 202–
SUMMARY:
E:\FR\FM\22AUN1.SGM
22AUN1
Agencies
[Federal Register Volume 81, Number 162 (Monday, August 22, 2016)]
[Notices]
[Page 56703]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19916]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0013]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection; Application for Permit to Import Controlled Substances for
Domestic and/or Scientific Purposes Pursuant to 21 U.S.C 952; DEA Form
357
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 60 days until
October 21, 2016.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Michael J. Lewis, Office of
Diversion Control, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202)
598-6812.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of this information collection:
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Application for Permit to Import
Controlled Substances for Domestic and/or Scientific Purposes pursuant
to 21 U.S.C. 952.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: DEA Form: 357. The applicable
component within the Department of Justice is the Drug Enforcement
Administration, Office of Diversion Control.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): None.
Abstract: Section 1002 of the Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal
Regulations (21 CFR), Sections 1312.11, 1312.12 and 1312.13 requires
any person who desires to import controlled substances listed in
schedules I or II, any narcotic substance listed in schedules III or
IV, or any non-narcotic substance in schedule III which the
Administrator has specifically designated by regulation in Sec.
1312.30, or any nonnarcotic substance in schedule IV or V which is also
listed in schedule I or II of the Convention on Psychotropic
Substances, must have an import permit. To obtain the permit to import
controlled substances for domestic and or scientific purposes, an
application for the permit must be made to the DEA on DEA Form 357.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 151 registrants participate in this information collection, taking
an estimated 0.25 hours per registrant annually.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates the total public burden
(in hours) associated with this collection: 333 annual burden hours.
If additional information is required please contact: Jerri Murray,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC
20530.
Dated: August 16, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-19916 Filed 8-19-16; 8:45 am]
BILLING CODE 4410-09-P